---
title: "Advantest pulled its 10,000-tester capacity target to end-2027, a year ahead of plan; the stock fell 7.4%"
description: "The chip-test giant told investors it will reach about 10,000 SoC testers of annual capacity by end-2027, a year ahead of plan, days after raising forecasts through a stock slide. For holders of Advantest and Teradyne, the question is whether test machines, not wafers, are the AI buildout's choke point."
publisher: "The Inference"
section: "Chips"
published: 2026-11-13T14:19:00.285Z
modified: 2026-11-13T14:19:00.285Z
canonical: https://theinference.org/article/advantest-pulled-its-10-000-tester-capacity-target-to-end-2027-a-year-ahead-of-plan-the-stock-fell-7-4
language: en
keywords: "Chip Testing, Semiconductor Equipment, Advantest, Teradyne, AI Chips"
---

# Advantest pulled its 10,000-tester capacity target to end-2027, a year ahead of plan; the stock fell 7.4%

> The chip-test giant told investors it will reach about 10,000 SoC testers of annual capacity by end-2027, a year ahead of plan, days after raising forecasts through a stock slide. For holders of Advantest and Teradyne, the question is whether test machines, not wafers, are the AI buildout's choke point.

## The ramp now has a date

[Advantest](https://theinference.org/markets/companies/advantest), the Japanese company whose machines test AI accelerators and memory chips before they ship, has put a date on its factory buildout: annual capacity of about 10,000 system-on-chip, or SoC, testers by the end of 2027, roughly a year earlier than its previous schedule, according to [a November 13 note from brokerage Longbridge](https://www.ad-hoc-news.de/boerse/news/corporate-news/advantest-stock-targets-10-000-soc-testers-by-end-2027/70503413) citing Advantest executives at an investor event [1].

The script of the fireside chat went up on Advantest's investor-relations page on November 12 [5]. Demand is not subtle. On [the October 28 earnings call](https://seekingalpha.com/article/4959004-advantest-corporation-ateyy-q2-2027-earnings-call-transcript), Group CEO Douglas Lefever said GPU and custom-ASIC orders are "running very hot" and that CPU demand is "probably the biggest factor" behind the raised outlook [4].

## The raise the market sold

The date extends [an October 28 forecast raise](https://www.ad-hoc-news.de/boerse/news/corporate-news/advantest-stock-slips-as-higher-forecast-raises-execution-stakes/70498974) that investors have already traded against [2]. First-half net sales rose 60.5 percent to ¥845.2 billion and net income jumped 116.8 percent to ¥368.1 billion; the full-year guide rose to ¥1,863.0 billion of sales and ¥967.0 billion of operating income, from ¥1,714.0 billion and ¥846.0 billion in July [2]. The stock still slipped 7.41 percent on November 12 [2]. Part of the discount is earnings quality: ¥54.2 billion of the half-year profit was valuation gains on financial instruments, while the core test-system business grew 61.2 percent [2].

*Chart: **October's raise lifted every fiscal 2026 line, operating income by ¥121 billion** Range chart comparing Advantest's July and October fiscal 2026 guidance for net sales, operating income and net income, in yen billions*

*Fiscal year ending March 31, 2027; July outlook versus October 28, 2026, revision; yen billions. Source: ad-hoc-news summary of Advantest results. [2]*

## The customers kept buying

[ChipMOS](https://theinference.org/markets/companies/chipmos-technologies), a Taiwan chip assembly and test house, filed the physical receipt: NT$805.5 million of machinery bought from Advantest Taiwan between April 8 and November 10, a purchase window that runs straight through the stock's slide [3][6], as [The Inference reported on November 10](https://theinference.org/article/chipmos-filed-nt-805-5-million-in-advantest-equipment-orders-that-ran-through-a-two-day-25-drop).

Its third quarter shows what the machines are for: record revenue of NT$8,400.8 million, net profit of NT$1,323.3 million, 3.8 times a year earlier, gross margin up to 21.7 percent from 12.4 percent, and utilization of 70 to 77 percent, from 57 to 70 percent [3][6].

October revenue rose 30.9 percent [7], and nine-month profit of NT$2.72 billion reversed a year-earlier loss [8]. [Teradyne](https://theinference.org/markets/companies/teradyne), Advantest's US rival, matched the picture: [third-quarter revenue up 70 percent to $1,306 million](https://finance.yahoo.com/markets/stocks/articles/teradyne-reports-third-quarter-2026-203000331.html) on record memory-test sales [9].

*Chart: **Teradyne's revenue is up 70% in a year and operating income nearly tripled** Line chart of Teradyne quarterly revenue and operating income from Q4 2023 to Q3 2026 in US dollars billions: revenue roughly doubles and operating income nearly triples*

*Quarterly, US$ billions, as reported. Teradyne's fiscal quarters end in late March, June, September and December. The step change arrives in Q4 2025 and holds through Q3 2026. Source: Teradyne quarterly figures from its SEC filings, retrieved 13 November 2026. [10]*

## What breaks the schedule

Advantest itself names component availability and supply-chain resilience as the priorities that decide whether orders become shipments, and it expects a record tester market in calendar 2026 [1][2]. Rising depreciation on ChipMOS's newly installed lines is the same constraint from the customer side, pressing on that 21.7 percent gross margin [3]. The orders say customers believe the test bottleneck is real; the share price, up just 2.08 percent in Tokyo on November 13 [5], says investors do not yet believe the schedule. Next readings: Advantest's semi-annual securities report, filed November 13 [2], and ChipMOS's November and December revenue prints [3].

## Takeaway

Advantest has pulled its 10,000 SoC tester capacity target forward to end-2027. Customers' machinery orders and Teradyne's record quarter say the test bottleneck is real; a 7.4% slide says investors doubt the schedule.

## Sources

1. [ad-hoc-news.de, "Advantest stock targets 10,000 SoC testers by end-2027", 13 November 2026](https://www.ad-hoc-news.de/boerse/news/corporate-news/advantest-stock-targets-10-000-soc-testers-by-end-2027/70503413)
2. [ad-hoc-news.de, "Advantest stock slips as higher forecast raises execution stakes", 12 November 2026](https://www.ad-hoc-news.de/boerse/news/corporate-news/advantest-stock-slips-as-higher-forecast-raises-execution-stakes/70498974)
3. [VLSI Korea, "ChipMOS Q3 Net Profit Nearly Quadruples to NT$1.32 Billion as Gross Margin Reaches 21.7% on Memory Volume", 13 November 2026](https://www.vlsi.kr/en/chipmos-q3-2026-flash-en/)
4. [Seeking Alpha, "Advantest Corporation (ATEYY) Q2 2027 Earnings Call Transcript", 28 October 2026](https://seekingalpha.com/article/4959004-advantest-corporation-ateyy-q2-2027-earnings-call-transcript)
5. [Advantest Corporation, Investors page (IR Fireside Chat Material, 12 November 2026; TSE 6857 quote, 13 November 2026)](https://www.advantest.com/en/investors/)
6. [MarketScreener / S&P Capital IQ, "ChipMOS TECHNOLOGIES INC. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026", 10 November 2026](https://www.marketscreener.com/news/chipmos-technologies-inc-reports-earnings-results-for-the-third-quarter-and-nine-months-ended-septe-ce785edade8cf022)
7. [Securities.io, "ChipMOS October Revenue Increases 30.9% to NT$2.85 Billion", 10 November 2026](https://www.securities.io/chipmos-october-revenue-increases-30-9-to-nt-2-85-billion/)
8. [US SEC EDGAR, ChipMOS Technologies Form 6-K, board resolutions and third-quarter 2026 consolidated statements, 10 November 2026](https://www.sec.gov/Archives/edgar/data/1123134/000119312526454337/imos-6-k-board_resolutio.htm)
9. [Business Wire via Yahoo Finance, "Teradyne Reports Third Quarter 2026 Results", 27 October 2026](https://finance.yahoo.com/markets/stocks/articles/teradyne-reports-third-quarter-2026-203000331.html)
10. [Teradyne, quarterly figures from its SEC filings, retrieved 13 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000097210)


---

Advantest pulled its 10,000-tester capacity target to end-2027, a year ahead of plan; the stock fell 7.4% — The Inference. Canonical: https://theinference.org/article/advantest-pulled-its-10-000-tester-capacity-target-to-end-2027-a-year-ahead-of-plan-the-stock-fell-7-4